Arbor Biotechnologies

Drug Discovery · Synthetic Biology
Sponsors visas
5Open roles1 posted in 30 days
$185kMedian advertised pay$110k – $200k−6% vs market
20 daysTime to fillmedian of 6 closed rolesmarket: 31 days

Facts

as of Nov 16, 2026

At Arbor Biotechnologies, we develop genetic medicines through our discovery of programmable DNA editors to enable curative outcomes for patients.

It is hiring: 5 open roles, 1 of them posted in the last 30 days.

Legal name
Arbor Biotechnologies, Inc.
Headquarters
Cambridge, United States
Founded
2016
Employees
201-500estimated range
Open roles
5Alion job postings
Register numbers
NAME arbor biotechnologies inc
Website
arbor.bio

As of Nov 16, 2026, Alion lists 5 open roles at Arbor Biotechnologies. Arbor Biotechnologies is headquartered in Cambridge, United States. It was founded in 2016. It has raised $230.6M in 2 funding rounds. The latest round is Venture - Series Unknown of $215M, announced in 2021. The median pay stated in its open roles is $185k, across 5 postings that state pay.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Legal entity active
Arbor Biotechnologies, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Hiring steadily, with new roles every week.

Biotech is the largest family, 50 of open roles.

1Posted in 30 days20% of open roles are fresh
20%Remote roles1 of 5
1Hiring offices
Can they hire you from United States?by your location
Likely
9 open roles are in your country: you apply locally, no move needed.
United States9On site
Remote, from elsewhere1Rare
No posting offers visa sponsorship. Remote roles: 1.
Time to fillmedian days to close a role
Arbor Biotechnologies20 days
Market, same roles31 days
Alion signals0-100
Demand6
Pay34
Your chance49
How badly they need people, whether they pay, how realistic getting in is.
Open roles over time−100%
Sep 21This week
Open roles a week: 2 then, 0 now
Where the openings areshare of open roles · trend
Biotech50▼
Science & Research30▼
Data Science20▲
Newest roles
Principal Research Associate, Protein Engineering
$95k – $110k per year · In office · Full-Time · 5+ years exp · Bachelor's Degree · Cambridge
Senior Research Associate, In Vivo Pharmacology
$85k – $95k per year · In office · Full-Time · 3+ years exp · Bachelor's Degree · Cambridge
Senior Clinical Trial Manager
$165k – $185k per year · Remote (United States) · Full-Time · Bachelor's Degree
Associate Director, Bioanalytical Sciences & Biomarkers
$185k – $200k per year · In office · Full-Time · 8+ years exp · PhD · Cambridge
Degree asked
Bachelor's Degree 60%Master's Degree 20%Doctoral Degree (PhD) 20%
5 postings state a degree.
Benefits named in postingsshare of open roles
Equity5100%
Parental leave5100%
Contract type
Full-Time 5
Visa sponsorship: none statedRelocation: none stated
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family

What its postings pay, by level.

$185kMedianmarket estimate $196k
$110k – $200kTypical rangeUSD a year
$240kHighest paying roleDirector, Analytical Development
Source: the pay stated in the company's postings, normalised to USD a year

Named in the work visa registers of United States.

0H-1B filings in 12 months
2Green card filings
$88kMedian offered salary

In the register as Arbor Biotechnologies, Inc., Cambridge, MA (+1 more)

Other sponsors in the same field
See 5 open roles Alert me
US Department of Labor · latest filing Jun 10, 2026

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
CambridgeBusiest site
SiteTypeOpen rolesHires most forEngineering
Cambridge United StatesHeadquarters4Biotech, Science & Research25%
Source: office addresses in postings and company registers

Financials

Funding rounds, investors and revenue on record.

$230.6MTotal raised
Venture - Series UnknownLatest round
2Rounds and grants
Money by yearUSD, rounds and grants
2021$215M1 record
2017$15.6M1 record
Largest rounds and grants
Sources: funding announcements, grant and company registers

Technologies named in job postings at Arbor Biotechnologies over the last 12 months, by layer, with the share of postings for each.

13Technologies in use
8Postings analysed
54/100Stack modernity
Cloud & platformsGCP
Sign in to see how your skills match this stackSign In
Full Arbor Biotechnologies tech stack13 technologies · by team · pay by technology · changes · similar stacks
Source: the technologies named in the company's postings and on its site

Milestones

Each milestone is dated by its source: registers, filings, the press

Newsroom

1Hacker News storiesbest: 1 points
Jun 252026
Blog
PARMA, Italy & CAMBRIDGE, MA, June 25, 2026 - Chiesi Group, an international research-oriented biopharmaceutical company, together with Arbor Biotechnologies, Inc., a biotechnolo…
May 182026
Blog
CAMBRIDGE, MA - May 18, 2026 - Arbor Biotechnologies, Inc., a biotechnology company discovering and developing the next generation of genetic medicines, today announced the appoi…
May 122026
Blog
CAMBRIDGE, MA - May 12, 2026 - Arbor Biotechnologies, Inc., a biotechnology company discovering and developing the next generation of genetic medicines, today announces the prese…
Apr 282026
Blog
CAMBRIDGE, MA - April 27, 2026 - Arbor Biotechnologies, Inc., a biotechnology company discovering and developing the next generation of genetic medicines, today announced three u…
Oct 30, 20252025
Blog
INCHEON, Korea - October 30, 2025 - Samsung Life Science Fund, created jointly between Samsung Biologics (KRX: 207940.KS), Samsung Bioepis, and Samsung C&T (KRX: 028260.KS), and…
Oct 6, 20252025
Blog
PARMA, ITALY & CAMBRIDGE, MA, USA - October 6, 2025 - Chiesi Group, an international research-oriented biopharmaceutical company, together with Arbor Biotechnologies, Inc., a nex…
Sources: the outlets named on each headline, each story once